Elevance Health raises FY26 adjusted EPS view to 'at least $27.00'

ELV Q2 adj EPS $7.45 tops consensus $6.21 on revs $49.8B vs. est. $48.63B; raises FY26 adjusted EPS view to 'at least $27.00' from prior view was FY26 adjusted EPS "at least $26.75," and above consensus $26.91; raises FY 2026 operating cash flow guidance to at least $6B; Medical cost ratio -- is expected to come in at 90.1%, versus 88.9% the same quarter last year; shares slide -3% premarket